查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1503423

到 2030 年預填充式注射器包裝市場預測：按類型、材料類型、分銷管道、應用、最終用戶和地區進行的全球分析

Prefilled Syringe Packaging Market Forecasts to 2030 - Global Analysis By Type (Single-Chamber, Dual-Chamber, Customized and Other Types), Material Type, Distribution Channel, Application, End User and By Geography
出版日期: | 出版商: Stratistics Market Research Consulting | 英文 200+ Pages | 商品交期: 2-3個工作天內

價格

根據 Stratistics MRC 的數據，全球預預填充式注射器包裝市場在預測期內將以 14.2% 的複合年成長率成長。

預填充式注射器包裝是一種專用的容器，旨在儲存和保護注射器內的疫苗和藥物等藥品，以供給藥。這些容器經過精心設計，可保持無菌，確保劑量準確，並保護內容物在使用前免受污染和損壞。包裝通常具有防篡改密封、無菌屏障和人體工學設計等功能，有助於在臨床環境中輕鬆操作和安全注射，從而提高醫療保健服務的便利性和安全性，並提高效率。

慢性病增加

慢性病的增加也是市場擴張的一個主要因素。隨著糖尿病、類風濕性關節炎和各種自體免疫疾病在全球範圍內的盛行率增加，對高效藥物傳輸系統的需求不斷增加。預填充式注射器具有方便、劑量準確和降低污染風險等優點，越來越受到醫療保健提供者和患者的青睞。這一趨勢證實了市場正在快速成長和發展，以有效應對醫療保健挑戰。

嚴格的監管要求

由於嚴格的監管要求，市場面臨重大挑戰。遵守各種安全和品質標準，包括衛生當局製定的標準，需要在製造、標籤和分銷過程中仔細注意細節。公司必須在研究、測試和文件方面投入大量資金，以確保其產品符合監管期望，這可能會延長交付時間並增加成本。遵守這些法規對於獲得市場核准和維持患者對預填充式注射器產品安全性和有效性的信心至關重要。

擴大自行注射裝置的採用

市面上自動注射器的採用率顯著增加。這一趨勢的推動因素是為治療糖尿病和類風濕性關節炎等慢性病的患者提供便利和控制。自動注射器可以在家中輕鬆、準確地進行藥物管理，減少醫療就診次數並提高病患的自主權。這一轉變代表了醫療保健服務的變革性演變，以回應患者對自我護理和個人化治療選擇日益成長的偏好。

高成本

市場面臨重大成本挑戰。特殊材料、嚴格的法規要求和複雜的組裝流程等因素推高了製造成本。此外，確保無菌性和與各種藥物的相容性也會增加成本。這些成本進一步受到對提高安全性和易用性的創新技術的需求的影響。公司不斷尋求提高效率，降低成本，同時維持產品品質和法規遵循。

COVID-19 的影響：

COVID-19 大流行對預填充式注射器包裝市場產生了重大影響，全球疫苗生產和分銷工作推動了需求的增加。製造商面臨著滿足日益成長的生產要求、同時確保供應鏈彈性和法規遵循的挑戰。包裝材料和滅菌技術的創新也已出現，以提高安全性和效率。儘管最初受到干擾，但隨著醫療保健系統優先考慮疫苗宣傳活動，市場不斷成長，凸顯了預填充式注射器在大流行應對和未來醫療保健策略中的關鍵作用。

預計疫苗產業在預測期內將是最大的產業。

由於易於管理、污染風險降低和劑量準確等優點，疫苗預計將在預測期內成為最大的市場。這種包裝形式也提高了疫苗的分發效率，特別是在偏遠和資源有限的地區。預填充式注射器的趨勢是由醫療保健專業人員對即用型解決方案的偏好所推動的，這些解決方案可以簡化疫苗接種流程並提高患者的依從性。

預計醫院業在預測期內複合年成長率最高。

預計醫院業在預測期內複合年成長率最高。預填充式注射器可提高效率、簡化藥物管理並最大限度地減少醫療機構的廢棄物。此外，預填充式注射器是首選，因為它們有助於感染控制通訊協定並且可以在緊急情況下立即使用。隨著醫院優先考慮以患者為中心的護理和業務效率，對預填充式注射器包裝的需求持續穩定成長。

比最大的地區

由於對即用型給藥系統的需求不斷成長，預計北美在預測期內將佔據最大的市場佔有率。關鍵因素包括生物技術的進步、慢性病盛行率的上升以及向自我給藥的轉變。促進安全性和便利性的監管措施進一步支持市場擴張。該地區競爭格局的特點是主要企業專注於包裝解決方案的創新和永續性，預計將持續成長。

複合年成長率最高的地區：

預計亞太地區在預測期內將維持最高的複合年成長率。隨著日本和韓國等國家人口持續老化，對需要使用預填充式注射器進行注射治療的慢性病治療的需求不斷增加。該地區的監管機構擴大核准預填充式注射器用於更廣泛的藥物配方，從而擴大了市場機會。預填充式注射器材料和設計的創新，包括提高針頭安全性和藥物穩定性，正在推動市場成長。

提供免費客製化：

訂閱此報告的客戶可以存取以下免費自訂選項之一：

  • 公司簡介
    • 其他市場參與者的綜合分析（最多 3 家公司）
    • 主要企業SWOT分析（最多3家企業）
  • 區域分割
    • 根據客戶興趣對主要國家的市場估計、預測和複合年成長率（註：基於可行性檢查）
  • 競爭基準化分析
    • 根據產品系列、地理分佈和策略聯盟對主要企業基準化分析

目錄

第1章執行摘要

第2章 前言

  • 概述
  • 相關利益者
  • 調查範圍
  • 調查方法
    • 資料探勘
    • 資料分析
    • 資料檢驗
    • 研究途徑
  • 研究資訊來源
    • 主要研究資訊來源
    • 二次研究資訊來源
    • 先決條件

第3章市場趨勢分析

  • 促進因素
  • 抑制因素
  • 機會
  • 威脅
  • 應用分析
  • 最終用戶分析
  • 新興市場
  • COVID-19 的影響

第4章波特五力分析

  • 供應商的議價能力
  • 買方議價能力
  • 替代品的威脅
  • 新進入者的威脅
  • 競爭公司之間的敵對關係

第5章全球預填充式注射器包裝市場：按類型

  • 單室
  • 雙腔室
  • 客製化
  • 其他類型

第6章全球預填充式注射器包裝市場：依材料類型

  • 塑膠
    • 聚丙烯
    • 環烯烴共聚物（COC）
    • 環烯烴聚合物（COP）
  • 玻璃

第7章全球預填充式注射器包裝市場：依通路分類

  • 直銷
  • 專業藥房
  • 零售藥房
  • 網路藥房

第8章全球預填充式注射器包裝市場：依應用分類

  • 疫苗
  • 單株抗體
  • 類風濕性關節炎
  • 過敏反應
  • 其他用途

第9章全球預填充式注射器包裝市場：依最終用戶分類

  • 日間手術中心 (ASC)
  • 居家照護環境
  • 醫院
  • 診所
  • 其他最終用戶

第10章全球預填充式注射器包裝市場：按地區

  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 德國
    • 英國
    • 義大利
    • 法國
    • 西班牙
    • 其他歐洲國家
  • 亞太地區
    • 日本
    • 中國
    • 印度
    • 澳洲
    • 紐西蘭
    • 韓國
    • 其他亞太地區
  • 南美洲
    • 阿根廷
    • 巴西
    • 智利
    • 南美洲其他地區
  • 中東/非洲
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 卡達
    • 南非
    • 其他中東和非洲

第11章 主要進展

  • 合約、夥伴關係、協作和合資企業
  • 收購和合併
  • 新產品發布
  • 業務擴展
  • 其他關鍵策略

第12章 公司概況

  • Becton, Dickinson and Company（BD）
  • Gerresheimer
  • Schott AG
  • Nipro Corporation
  • AptarGroup, Inc.
  • SHL Group
  • Weigao Group
  • Haselmeier GmbH
  • Lonza Group
  • Zeon Corporation
  • Syntegon Technology GmbH
  • West Pharmaceutical Services, Inc.
  • ROVI Contract Manufacturing
  • Catalent, Inc.
  • Terumo Corporation
  • Topas Advanced Polymers GmbH
Product Code: SMRC26593

According to Stratistics MRC, the Global Prefilled Syringe Packaging Market is growing at a CAGR of 14.2% during the forecast period. Prefilled syringe packaging is the specialized containers designed to store and protect pharmaceutical products, such as vaccines or medications, within a syringe ready for administration. These containers are meticulously engineered to maintain sterility, ensure accurate dosage delivery, and safeguard the contents from contamination or damage until use. The packaging typically includes features like tamper-evident seals, sterile barriers, and ergonomic designs that facilitate easy handling and safe injection practices in clinical settings, thereby enhancing convenience, safety, and efficiency in healthcare delivery.

Market Dynamics:

Driver:

Rising prevalence of chronic diseases

The rising prevalence of chronic diseases is a key driver in the expansion of the market. As the incidence of conditions such as diabetes, rheumatoid arthritis, and various autoimmune diseases increases globally, there is a growing demand for efficient drug delivery systems. Prefilled syringes offer advantages in terms of convenience, accuracy of dosage, and reduced risk of contamination, making them increasingly favored by healthcare providers and patients alike. This trend underscores the market's rapid growth and evolution towards meeting healthcare challenges effectively.

Restraint:

Stringent regulatory requirements

The market faces significant challenges due to stringent regulatory requirements. Compliance with various safety and quality standards, including those set by health authorities demands meticulous attention to detail in manufacturing, labeling, and distribution processes. Companies must invest heavily in research, testing, and documentation to ensure products meet regulatory expectations, which can lead to extended timelines and increased costs. Adherence to these regulations is crucial for gaining market approval and maintaining patient trust in the safety and efficacy of prefilled syringe products.

Opportunity:

Growing adoption of self-injection devices

The market is experiencing a significant rise in self-injection device adoption. This trend is driven by the convenience and control it offers to patients managing chronic conditions such as diabetes and rheumatoid arthritis. Self-injection devices enable easy and accurate administration of medication at home, reducing healthcare visits and enhancing patient autonomy. This shift marks a transformative evolution in healthcare delivery, catering to the growing preference for self-care and personalized treatment options among patients globally.

Threat:

High cost

The market faces significant cost challenges. Factors such as specialized materials, stringent regulatory requirements, and complex assembly processes contribute to high production costs. Additionally, ensuring sterility and compatibility with various drugs adds to expenses. These costs are further impacted by the need for innovative technologies to improve safety and usability. Companies are continually seeking efficiencies to mitigate costs while maintaining product quality and regulatory compliance.

Covid-19 Impact:

The COVID-19 pandemic significantly impacted the Prefilled Syringe Packaging market, driving increased demand due to vaccine production and distribution efforts worldwide. Manufacturers faced challenges in meeting heightened production requirements while ensuring supply chain resilience and regulatory compliance. Innovations in packaging materials and sterilization techniques also emerged to enhance safety and efficiency. Despite initial disruptions, the market experienced growth as healthcare systems prioritized vaccination campaigns, highlighting the critical role of prefilled syringes in pandemic response and future healthcare strategies.

The vaccines segment is expected to be the largest during the forecast period

The vaccines is expected to be the largest during the forecast period due to advantages such as ease of administration, reduced risk of contamination, and precise dosing accuracy. This packaging format also enhances vaccine distribution efficiency, particularly in remote and resource-limited areas. The trend towards prefilled syringes is driven by healthcare professionals' preference for ready-to-use solutions, which streamline vaccination processes and improve patient compliance.

The hospitals segment is expected to have the highest CAGR during the forecast period

The hospitals segment is expected to have the highest CAGR during the forecast period. These attributes enhance efficiency in healthcare settings, streamline medication administration, and minimize waste. Additionally, prefilled syringes contribute to infection control protocols and are favored in emergency situations for their immediate usability. As hospitals prioritize patient-centric care and operational efficiency, the demand for prefilled syringe packaging continues to grow steadily.

Region with largest share:

North America is projected to hold the largest market share during the forecast period driven by increasing demand for ready-to-use drug delivery systems. Key factors include advancements in biotechnology, rising prevalence of chronic diseases and a shift towards self-administration of drugs. Regulatory initiatives promoting safety and convenience further propel market expansion. The region's competitive landscape features prominent players focusing on innovation and sustainability in packaging solutions, anticipating continued growth.

Region with highest CAGR:

Asia Pacific is projected to hold the highest CAGR over the forecast period. The aging population in countries like Japan and South Korea is boosting the demand for chronic disease treatments, which often require injectable therapies delivered via prefilled syringes. Regulatory agencies in the region are increasingly approving prefilled syringes for a wider range of drug formulations, which expands the market opportunities. Innovations in prefilled syringe materials and designs, including advancements in needle safety and drug stability, are driving market growth.

Key players in the market

Some of the key players in Prefilled Syringe Packaging market include Becton, Dickinson and Company (BD), Gerresheimer, Schott AG, Nipro Corporation, AptarGroup, Inc., SHL Group, Weigao Group, Haselmeier GmbH, Lonza Group, Zeon Corporation, Syntegon Technology GmbH, West Pharmaceutical Services, Inc. , ROVI Contract Manufacturing, Catalent, Inc., Terumo Corporation and Topas Advanced Polymers GmbH.

Key Developments:

In March 2024, SCHOTT Pharma expanded in the U.S. with New Prefillable Syringe Manufacturing Facility in Wilson, North Carolina. The new site will expand the U.S. supply chain for in-demand syringes that deliver lifesaving injectable medicines, vaccines, and other fields of applications, allowing SCHOTT Pharma to triple its contribution of glass and polymer syringes to the U.S. market by 2030.

In March 2023, SCHOTT launched production of amber pharma glass in India to meet increasing demand. Strategic move increases availability of borosilicate glass variations to manufacturers of pharma packaging in India and Asia

Types Covered:

  • Single-Chamber
  • Dual-Chamber
  • Customized
  • Other Types

Material Types Covered:

  • Plastic
  • Glass

Distribution Channels Covered:

  • Direct Sales
  • Specialty Pharmacies
  • Retail Pharmacies
  • Online Pharmacies

Applications Covered:

  • Vaccines
  • Monoclonal Antibodies
  • Rheumatoid Arthritis
  • Anaphylaxis
  • Other Applications

End Users Covered:

  • Ambulatory Surgical Centers (ASCs)
  • Home Care Settings
  • Hospitals
  • Clinics
  • Other End Users

Regions Covered:

  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • Italy
    • France
    • Spain
    • Rest of Europe
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • New Zealand
    • South Korea
    • Rest of Asia Pacific
  • South America
    • Argentina
    • Brazil
    • Chile
    • Rest of South America
  • Middle East & Africa
    • Saudi Arabia
    • UAE
    • Qatar
    • South Africa
    • Rest of Middle East & Africa

What our report offers:

  • Market share assessments for the regional and country-level segments
  • Strategic recommendations for the new entrants
  • Covers Market data for the years 2022, 2023, 2024, 2026, and 2030
  • Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
  • Strategic recommendations in key business segments based on the market estimations
  • Competitive landscaping mapping the key common trends
  • Company profiling with detailed strategies, financials, and recent developments
  • Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

  • Company Profiling
    • Comprehensive profiling of additional market players (up to 3)
    • SWOT Analysis of key players (up to 3)
  • Regional Segmentation
    • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
  • Competitive Benchmarking
    • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

2 Preface

  • 2.1 Abstract
  • 2.2 Stake Holders
  • 2.3 Research Scope
  • 2.4 Research Methodology
    • 2.4.1 Data Mining
    • 2.4.2 Data Analysis
    • 2.4.3 Data Validation
    • 2.4.4 Research Approach
  • 2.5 Research Sources
    • 2.5.1 Primary Research Sources
    • 2.5.2 Secondary Research Sources
    • 2.5.3 Assumptions

3 Market Trend Analysis

  • 3.1 Introduction
  • 3.2 Drivers
  • 3.3 Restraints
  • 3.4 Opportunities
  • 3.5 Threats
  • 3.6 Application Analysis
  • 3.7 End User Analysis
  • 3.8 Emerging Markets
  • 3.9 Impact of Covid-19

4 Porters Five Force Analysis

  • 4.1 Bargaining power of suppliers
  • 4.2 Bargaining power of buyers
  • 4.3 Threat of substitutes
  • 4.4 Threat of new entrants
  • 4.5 Competitive rivalry

5 Global Prefilled Syringe Packaging Market, By Type

  • 5.1 Introduction
  • 5.2 Single-Chamber
  • 5.3 Dual-Chamber
  • 5.4 Customized
  • 5.5 Other Types

6 Global Prefilled Syringe Packaging Market, By Material Type

  • 6.1 Introduction
  • 6.2 Plastic
    • 6.2.1 Polypropylene
    • 6.2.2 Cyclic Olefin Copolymer (COC)
    • 6.2.3 Cyclic Olefin Polymer (COP)
  • 6.3 Glass

7 Global Prefilled Syringe Packaging Market, By Distribution Channel

  • 7.1 Introduction
  • 7.2 Direct Sales
  • 7.3 Specialty Pharmacies
  • 7.4 Retail Pharmacies
  • 7.5 Online Pharmacies

8 Global Prefilled Syringe Packaging Market, By Application

  • 8.1 Introduction
  • 8.2 Vaccines
  • 8.3 Monoclonal Antibodies
  • 8.4 Rheumatoid Arthritis
  • 8.5 Anaphylaxis
  • 8.6 Other Applications

9 Global Prefilled Syringe Packaging Market, By End User

  • 9.1 Introduction
  • 9.2 Ambulatory Surgical Centers (ASCs)
  • 9.3 Home Care Settings
  • 9.4 Hospitals
  • 9.5 Clinics
  • 9.6 Other End Users

10 Global Prefilled Syringe Packaging Market, By Geography

  • 10.1 Introduction
  • 10.2 North America
    • 10.2.1 US
    • 10.2.2 Canada
    • 10.2.3 Mexico
  • 10.3 Europe
    • 10.3.1 Germany
    • 10.3.2 UK
    • 10.3.3 Italy
    • 10.3.4 France
    • 10.3.5 Spain
    • 10.3.6 Rest of Europe
  • 10.4 Asia Pacific
    • 10.4.1 Japan
    • 10.4.2 China
    • 10.4.3 India
    • 10.4.4 Australia
    • 10.4.5 New Zealand
    • 10.4.6 South Korea
    • 10.4.7 Rest of Asia Pacific
  • 10.5 South America
    • 10.5.1 Argentina
    • 10.5.2 Brazil
    • 10.5.3 Chile
    • 10.5.4 Rest of South America
  • 10.6 Middle East & Africa
    • 10.6.1 Saudi Arabia
    • 10.6.2 UAE
    • 10.6.3 Qatar
    • 10.6.4 South Africa
    • 10.6.5 Rest of Middle East & Africa

11 Key Developments

  • 11.1 Agreements, Partnerships, Collaborations and Joint Ventures
  • 11.2 Acquisitions & Mergers
  • 11.3 New Product Launch
  • 11.4 Expansions
  • 11.5 Other Key Strategies

12 Company Profiling

  • 12.1 Becton, Dickinson and Company (BD)
  • 12.2 Gerresheimer
  • 12.3 Schott AG
  • 12.4 Nipro Corporation
  • 12.5 AptarGroup, Inc.
  • 12.6 SHL Group
  • 12.7 Weigao Group
  • 12.8 Haselmeier GmbH
  • 12.9 Lonza Group
  • 12.10 Zeon Corporation
  • 12.11 Syntegon Technology GmbH
  • 12.12 West Pharmaceutical Services, Inc.
  • 12.13 ROVI Contract Manufacturing
  • 12.14 Catalent, Inc.
  • 12.15 Terumo Corporation
  • 12.16 Topas Advanced Polymers GmbH

List of Tables

  • Table 1 Global Prefilled Syringe Packaging Market Outlook, By Region (2022-2030) ($MN)
  • Table 2 Global Prefilled Syringe Packaging Market Outlook, By Type (2022-2030) ($MN)
  • Table 3 Global Prefilled Syringe Packaging Market Outlook, By Single-Chamber (2022-2030) ($MN)
  • Table 4 Global Prefilled Syringe Packaging Market Outlook, By Dual-Chamber (2022-2030) ($MN)
  • Table 5 Global Prefilled Syringe Packaging Market Outlook, By Customized (2022-2030) ($MN)
  • Table 6 Global Prefilled Syringe Packaging Market Outlook, By Other Types (2022-2030) ($MN)
  • Table 7 Global Prefilled Syringe Packaging Market Outlook, By Material Type (2022-2030) ($MN)
  • Table 8 Global Prefilled Syringe Packaging Market Outlook, By Plastic (2022-2030) ($MN)
  • Table 9 Global Prefilled Syringe Packaging Market Outlook, By Polypropylene (2022-2030) ($MN)
  • Table 10 Global Prefilled Syringe Packaging Market Outlook, By Cyclic Olefin Copolymer (COC) (2022-2030) ($MN)
  • Table 11 Global Prefilled Syringe Packaging Market Outlook, By Cyclic Olefin Polymer (COP) (2022-2030) ($MN)
  • Table 12 Global Prefilled Syringe Packaging Market Outlook, By Glass (2022-2030) ($MN)
  • Table 13 Global Prefilled Syringe Packaging Market Outlook, By Distribution Channel (2022-2030) ($MN)
  • Table 14 Global Prefilled Syringe Packaging Market Outlook, By Direct Sales (2022-2030) ($MN)
  • Table 15 Global Prefilled Syringe Packaging Market Outlook, By Specialty Pharmacies (2022-2030) ($MN)
  • Table 16 Global Prefilled Syringe Packaging Market Outlook, By Retail Pharmacies (2022-2030) ($MN)
  • Table 17 Global Prefilled Syringe Packaging Market Outlook, By Online Pharmacies (2022-2030) ($MN)
  • Table 18 Global Prefilled Syringe Packaging Market Outlook, By Application (2022-2030) ($MN)
  • Table 19 Global Prefilled Syringe Packaging Market Outlook, By Vaccines (2022-2030) ($MN)
  • Table 20 Global Prefilled Syringe Packaging Market Outlook, By Monoclonal Antibodies (2022-2030) ($MN)
  • Table 21 Global Prefilled Syringe Packaging Market Outlook, By Rheumatoid Arthritis (2022-2030) ($MN)
  • Table 22 Global Prefilled Syringe Packaging Market Outlook, By Anaphylaxis (2022-2030) ($MN)
  • Table 23 Global Prefilled Syringe Packaging Market Outlook, By Other Applications (2022-2030) ($MN)
  • Table 24 Global Prefilled Syringe Packaging Market Outlook, By End User (2022-2030) ($MN)
  • Table 25 Global Prefilled Syringe Packaging Market Outlook, By Ambulatory Surgical Centers (ASCs) (2022-2030) ($MN)
  • Table 26 Global Prefilled Syringe Packaging Market Outlook, By Home Care Settings (2022-2030) ($MN)
  • Table 27 Global Prefilled Syringe Packaging Market Outlook, By Hospitals (2022-2030) ($MN)
  • Table 28 Global Prefilled Syringe Packaging Market Outlook, By Clinics (2022-2030) ($MN)
  • Table 29 Global Prefilled Syringe Packaging Market Outlook, By Other End Users (2022-2030) ($MN)

Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.